drugset / Trial / NCT00681148

Botulinum Toxin Injection With Prostate Brachytherapy

NCT00681148 ↗

Phase 2 Withdrawn Emory University
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to see if botox injection into the prostate during seed implantation (brachytherapy) for prostate cancer a) improves urinary symptoms or avoids need for urinary tract instrumentation over the 6-8 month post-operative period when one wants to avoid manipulating the radioactive seeds, and b) speeds up the drop in PSA. Patients will be randomized to botox vs saline injection, at the completion of the seed implantation procedure.

Timeline

Start
—
Primary completion
2012-07
Completion
2012-07

Outcome

Outcome not reported

Stopped (Business): “No funding”

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 100 iu Other
Subject Botulinum toxin type A Protein / enzyme biologic 200 iu Other

Indications